| |
| |
|
| Insider
Information: |
Silva Paul M |
| Relationship: |
SVP & Chief Accounting... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,884 |
|
|
Indirect Shares
|
169 |
|
|
| Direct
Value |
$4,685,016 |
|
|
|
Indirect Value
|
$80,106 |
|
|
| Total
Shares |
10,053 |
|
|
| Total
Value |
$4,765,122 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP & Chief Accounting... |
2021-03-01 |
9,884 |
2021-03-01 |
169 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-07-13 |
4 |
AS |
$284.56 |
$251,145 |
D/D |
(860) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-08-03 |
4 |
AS |
$276.00 |
$225,142 |
D/D |
(809) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-05-15 |
4 |
AS |
$275.71 |
$42,885 |
D/D |
(151) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-08-06 |
4 |
AS |
$270.12 |
$292,319 |
D/D |
(1,078) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-05-06 |
4 |
AS |
$269.41 |
$293,472 |
D/D |
(1,076) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-05-04 |
4 |
AS |
$259.21 |
$211,048 |
D/D |
(809) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-04-06 |
4 |
AS |
$255.57 |
$1,249,993 |
D/D |
(4,891) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-04-13 |
4 |
AS |
$244.09 |
$213,650 |
D/D |
(859) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-11 |
4 |
AS |
$243.59 |
$1,442,301 |
D/D |
(5,862) |
19,688 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-18 |
4 |
AS |
$241.95 |
$380,957 |
D/D |
(1,564) |
16,876 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-17 |
4 |
D |
$241.50 |
$301,392 |
D/D |
(1,248) |
18,440 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-10 |
4 |
D |
$240.95 |
$1,125,959 |
D/D |
(4,673) |
25,550 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-24 |
4 |
D |
$239.23 |
$206,695 |
D/D |
(864) |
16,012 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-06 |
4 |
AS |
$238.73 |
$111,523 |
D/D |
(466) |
30,223 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-01-31 |
4 |
AS |
$238.65 |
$333,155 |
D/D |
(1,396) |
17,759 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-01-08 |
4 |
AS |
$231.89 |
$3,188,488 |
D/D |
(13,750) |
17,759 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-25 |
4 |
AS |
$229.66 |
$252,127 |
D/D |
(1,080) |
14,932 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-02-03 |
4 |
AS |
$228.91 |
$484,939 |
D/D |
(2,099) |
17,759 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Controller |
• – – |
2020-01-02 |
4 |
AS |
$217.68 |
$5,610,993 |
D/D |
(25,630) |
17,759 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$187,980 |
D/D |
(864) |
15,964 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$139,418 |
D/D |
(651) |
25,361 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-26 |
4 |
D |
$212.42 |
$471,148 |
D/D |
(2,218) |
12,666 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-25 |
4 |
AS |
$211.80 |
$230,552 |
D/D |
(1,080) |
14,884 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-17 |
4 |
D |
$211.75 |
$580,195 |
D/D |
(2,740) |
21,123 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Accounting Officer |
• – – |
2021-02-11 |
4 |
AS |
$210.45 |
$315,437 |
D/D |
(1,498) |
23,863 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
